La Financiere de L'Echiquier’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
La Financiere de L'Echiquier's REGN Position: Q2 2024 in Review
La Financiere de L'Echiquier reduced its Regeneron Pharmaceuticals (REGN) stake by 19% in Q2 2024, selling an estimated $82.4K and leaving 355 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #90.
La Financiere de L'Echiquier first reported a position in REGN in Q2 2023 and has held it in 5 quarters since. The position peaked at $457K in Q4 2023. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2024.
- La Financiere de L'Echiquier held 355 shares of Regeneron Pharmaceuticals worth $373K as of Q2 2024.
- La Financiere de L'Echiquier sold 85 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $82.4K.
- Regeneron Pharmaceuticals made up 0.02% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #90 holding.
- La Financiere de L'Echiquier first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
- La Financiere de L'Echiquier's Regeneron Pharmaceuticals position peaked at $457K in Q4 2023.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.
Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.